|
|
 |
|
Viewing report
|
|
|
|
Royalty Rates in Biotech:A BVR's Guide to Full-Text Licensing Agreements
Business Valuation Resources, June 2010, Pages: 543
Intellectual property valuations occur in the biotech industry for a number of reasons, including licensing, transfer pricing, mergers and acquitions, collateral and litigation.
In order to make an agreement to license intellectual property rights (IPR), either incoming or outgoing, the parties must know as accurately as possible the real value of the IPR. Additionally, some licensing agreements specifically address non-cash, non-equity exchanges, calling for fair market valuations of the assets exchanged.
To assist in constructing these agreements, BVR has published the Royalty Rates in Biotech guide, which contains over 500 pages of full text copies of actual licensing agreements in the biotech industry.
These hard-to-find agreements will provide valuable guidance in setting royalty rates and addressing complex issues in a license agreement.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics, 2nd Edition
Building Biotech Technology Transfer Opportunities: Sponsor and Developer Strategies for Success
Pharmaceutical Licensing Strategies: Best Practices in Deal-Making, Valuations and Strategic Management
Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics, 2nd Edition
Biotech Financing in the Credit Crisis: Strategies for a radically altered landscape
Clinical Stage Partnering Terms and Agreements in Pharma and Biotech, 2nd Edition
The Fastest Growing Biotechnology Companies: Growth Strategies, Comparative Analyses and Company Profiles
The Funding Landscape for Small Biopharma Ventures, 2010-2015: Trends, Strategies and Priorities
Discovery Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics, 2nd Edition
Pre-Clinical Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics, 2nd Edition
|
|
|
|
